Supernus Pharmaceuticals (SUPN) Non Operating Income (2011 - 2026)
Supernus Pharmaceuticals' Non Operating Income was $315,000 in Q2 2026, down 93.0% from $4.53 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Non Operating Income (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Supernus Pharmaceuticals' Non Operating Income was $9.14 million through Jun 30, 2026, down 49.3% year-over-year; for FY2025, it was $13.25 million, down 18.2% from FY2024.
- Non Operating Income shows a three-year compound annual growth rate of -3.2% (FY2022 to FY2025).
- In earlier years, Non Operating Income was $16.2 million in FY2024 (+101.6%), $8.04 million in FY2023 (-45.0%) and $14.62 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Non Operating Income since Q2 2022.
- Compared with a year earlier, Non Operating Income was higher in four of the last seven quarters, with growth averaging 19.9%.
- The best year-over-year quarter for Non Operating Income over five years was Q2 2024 (growth of 711.5%); the worst was Q2 2026 (a decline of 93.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.39 Bn | 1.04 Bn | 185.39 Mn | 315,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 315,000.00 |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 4.53 Mn |
| Mar 31, 2025 | 4.43 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 460,000.00 |
| Mar 31, 2023 | 3.84 Mn |
| Dec 31, 2022 | 806,000.00 |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | -22,000.00 |
| Mar 31, 2022 | 12.76 Mn |
| Sep 30, 2021 | -3.64 Mn |
| Jun 30, 2021 | -2.88 Mn |
| Mar 31, 2021 | -2.29 Mn |
API Access
Supernus Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();